Literature DB >> 6354702

Pathophysiology of acromegaly.

S Melmed, G D Braunstein, E Horvath, C Ezrin, K Kovacs.   

Abstract

This review discusses the pathophysiology of acromegaly. Acromegaly has been classified in this paper into distinct entities based on etiology, ultrastructural features of the pituitary, and cytogenesis. This classification has been proposed based on clinical signs, immunoperoxidase techniques, transmission electromicroscopy and immunoelectron microscopy. Pituitary causes of acromegaly include densely granulated adenomas, sparsely granulated adenomas, mixed growth hormone and prolactin cell adenomas, acidophil stem cell adenomas, mammosomatotroph cell adenomas, and pleurihormonal adenomas. GH cell hyperplasia and GH cell carcinoma are also discussed. Extrapituitary causes of acromegaly include eutopic GH cell adenoma in the sphenoid sinus or parapharyngeal region and excess GHRF secretion which may be eutopic or ectopic. The pathological, clinical, and biochemical evidence in favor of a pituitary or hypothalamic etiology of acromegaly has been reviewed. Finally, a multistage theory of GH cell tumorigenesis has been proposed as a model in an attempt to unify the genetic, environmental and biochemical factors implicated in the pathogenesis of acromegaly.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354702     DOI: 10.1210/edrv-4-3-271

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  26 in total

1.  Case report: acromegaly.

Authors:  A D D'Urzo
Journal:  Can Fam Physician       Date:  1997-06       Impact factor: 3.275

Review 2.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

3.  Transferrin and transferrin receptor in human hypophysis and pituitary adenomas.

Authors:  A Tampanaru-Sarmesiu; L Stefaneanu; K Thapar; G Kontogeorgos; T Sumi; K Kovacs
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  A structural and functional acromegaly classification.

Authors:  Daniel Cuevas-Ramos; John D Carmichael; Odelia Cooper; Vivien S Bonert; Arkadiusz Gertych; Adam N Mamelak; Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

5.  Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.

Authors:  R V Lloyd; M Cano; W F Chandler; A L Barkan; E Horvath; K Kovacs
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

6.  Clinical acromegaly with undetectable growth hormone and hyperprolactinemia.

Authors:  L J Valenta; A N Elias
Journal:  J Natl Med Assoc       Date:  1987-05       Impact factor: 1.798

Review 7.  Regulation of growth hormone secretion in man: a review.

Authors:  D G Johnston; R R Davies; R W Prescott
Journal:  J R Soc Med       Date:  1985-04       Impact factor: 5.344

Review 8.  Management of aggressive growth hormone secreting pituitary adenomas.

Authors:  Daniel A Donoho; Namrata Bose; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

9.  A prospective multicenter octreotide dose response study in the treatment of acromegaly.

Authors:  S Ezzat; D A Redelmeier; M Gnehm; A G Harris
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

Review 10.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.